[1]McKeown-Eyssen G.Epidemiology of colorectal cancer revisited: Are serum triglycerides and/or plasma glucose associated with risk[J].Cancer Epidemiol Biomarkers Prev,1994,3(8):687-695.
[2]Chung YW, Han DS, Park KH,et al.Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus: a case-control study in Korea[J].Dis Colon Rectum,2008,51(5): 593-597.
[3]La Vecchia C, Negri E, Decarli A,et al.Diabetes mellitus and colorectal cancer risk[J].Cancer Epidemiol Biomarkers Prev,1997,6(12):1007-1010.
[4]Larsson SC, Orsini N, Wolk A.Diabetes mellitus and risk of colorectal cancer: a meta-analysis[J].J Natl Cancer Inst,2005,97(22):1679-1687.
[5]Khaw KT, Wareham N, Bingham S, et al. Preliminary communication:glycated hemoglobin diabetes and incident colorectal cancer in men and women, a prospective analysis from the European prospective investigation into cancer-morfolk study[J].Cancer Epidemiol Biomarker Prev, 2004,13(6):915-919.
[6]Schoen RE, Weissfeld JL, Kuller LH,et al.Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps[J]. Gastroenterology,2005,129(2):464-475.
[7]Ma J, Giovannucci E, Pollak M,et al.A prospective study of plasma C-peptide and colorectal cancer risk in men[J].J Natl Cancer Inst,2004,96(7):546-553.
[8]Renehan AG, Zwahlen M, Minder C,et al.Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis[J].Lancet,2004,363(9418):1346-1353.
[9]Bowers K, Albanes D, Limburg P,et al.A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers[J].Am J Epidemiol,2006,164(7):652-664.
[10]Colao A, Pivonello R, Auriemma RS,et al.The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients[J].J Clin Endocrinol Metab,2007,92(10):3854-3860.
[11]Misra UK, Pizzo SV.Up-regulation of GRP78 and antiapoptotic signaling in murine peritoneal macrophages exposed to insulin[J]. J Leukoc Biol, 2005,78(10):187-194.
[12]Keku TO, Lund PK, Galanko J,et al.Insulin resistance, apoptosis, and colorectal adenoma risk[J].Cancer Epidemiol Biomarkers Prev,2005,14(9): 2076-2081.
[13]Morimoto LM, Newcomb PA, White E,et al.Insulin-like growth factor polymorphisms and colorectal cancer risk[J].Cancer Epidemiol Biomarkers Prev,2005,14(10):1204-1211.
[14]Conti L, Regis G, Longo A,et al.In the absence of IGF-1 signaling, IFN-suppresses human malignant T-cell growth[J].Blood,2007,109(6):2496-2504.
[15]Stearns M, Tran J, Francis M,et al.Activated Ras enhances insulin-like growth factor I induction of vascular endothelial growth factor in prostate epithelial cells[J]. Cancer Res,2005,65(6): 2085-2088.
[16]Swede H, Rohan TE, Yu H,et al.Number of aberrant crypt foci associated with adiposity and IGF1 bioavailability[J].Cancer Causes Control,2009,20(5):653-661.
[17]Raju J, Bird RP.Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor {beta} and cyclooxygenase isoforms in Zucker obese (fa/fa) rats[J]. Cancer Res,2003,63(20):6595-6601.
[18]Tran TT, Medline A, Bruce WR,et al.Insulin promotion of colon tumours in rats[J].Cancer Epidemiol Biomarkers Prev,1996,5(12):1013-1015.
[19]Tran TT, Naigamwalla D, Oprescu AI,et al.Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo[J].Endocrinology,2006,147(4):1830-1837.
[20]Lee WM, Lu S, Medline A,et al.Susceptibility of lean and obese Zucker rats to tumourigenesis induced by N-methyl-N-nitrosourea[J]. Cancer Lett, 2001,162(2):155-160.
[21]Dunn SE, Kari FW, French J,et al.Dietary restriction reduces insulin-like growth factor I levels which modulates apoptosis cell proliferation and tumour progression in p53-deficient mice[J].Cancer Res,1997,57(21):4667-4672.
[22]Wu Y, Yakar S, Zhao L,et al.Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis[J].Cancer Res,2002,62(4):1030-1035.
[23]Hawk ET, Levin B.Colorectal cancer prevention[J]. J Clin Oncol, 2005, 23(2):378-391.
[24]Bleiberg H, Autier P, Huet F,et al.Colorectal cancer (CRC) screening using sigmoidoscopy followed by colonoscopy: a feasibility and efficacy study on a cancer institute based population[J].Ann Onc,2006,17(8):1328-1332.
[25]Smith RA, Cokkinides V, Eyre HJ.American cancer society guidelines for the early detection of cancer 2005[J].CA Cancer J Clin,2005,55(1):31-44.
[26]Rabeneck L, Paszat LF, Hilsden RJ,et al.Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice[J].Gastroenterology,2008,135(6):1899-1906.
[27]Pickhardt PJ, Choi JR, Hwang I,et al.Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults[J]. N Engl J Med,2003,349(23):2191-2200. |